Neuroscience of Psychoactive Substance Use and Dependence Summary World Health Organization Geneva Who Library Cataloguing-in-publication Data

Neuroscience of psychoactive substance use and dependence : summary.

[1]  J. Stephenson.  World health report. , 2004, Lancet.

[2]  B. Price,et al.  Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review. , 2002, Harvard review of psychiatry.

[3]  B. Everitt,et al.  Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex , 2002, Neuroscience & Biobehavioral Reviews.

[4]  J S Fowler,et al.  Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. , 2001, The American journal of psychiatry.

[5]  J. Hewitt,et al.  Common genetic and environmental vulnerability for alcohol and tobacco use in a volunteer sample of older female twins. , 2001, Journal of studies on alcohol.

[6]  G. Whelan,et al.  Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. , 2001, Alcohol and alcoholism.

[7]  M. Tsuang,et al.  The Harvard Twin Study of Substance Abuse: what we have learned. , 2001, Harvard review of psychiatry.

[8]  H. Kalant,et al.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[9]  R. Horton,et al.  Sponsorship, authorship, and accountability , 2001, The Lancet.

[10]  P. Vallance.  Releasing the grip of big pharma , 2001, The Lancet.

[11]  A. Flanagin,et al.  Reporting financial conflicts of interest and relationships between investigators and research sponsors. , 2001, Journal of the American Medical Association (JAMA).

[12]  D. Goldman,et al.  The genetics of alcoholism and alcohol abuse , 2001, Current psychiatry reports.

[13]  J S Fowler,et al.  Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. , 2001, The American journal of psychiatry.

[14]  H. Kranzler,et al.  Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. , 2000, Alcohol and alcoholism.

[15]  W. Iacono,et al.  Genetic and environmental influences on adolescent substance use and abuse. , 2000, American journal of medical genetics.

[16]  K. Berridge,et al.  The psychology and neurobiology of addiction: an incentive-sensitization view. , 2000, Addiction.

[17]  D. Carmelli,et al.  A genetic analysis of smoking behavior in family members of older adult males. , 2000, Addiction.

[18]  J. Nurnberger,et al.  Clinical correlates of cigarette smoking and nicotine dependence in alcohol-dependent men and women. The Collaborative Study Group on the Genetics of Alcoholism. , 2000, Alcohol and alcoholism.

[19]  W. Iacono,et al.  Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins: univariate and multivariate behavioral genetic analyses. , 1999, Addiction.

[20]  K. Kendler,et al.  Sex differences in the sources of genetic liability to alcohol abuse and dependence in a population-based sample of U.S. twins. , 1999, Alcoholism, clinical and experimental research.

[21]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[22]  P. Sullivan,et al.  Susceptibility genes for nicotine dependence: a genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study , 1999, Molecular Psychiatry.

[23]  D. Kronick.  The Ethics of Biomedical Research: An International Perspective , 1999 .

[24]  Gerald L. Brown,et al.  Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. , 1998, Archives of general psychiatry.

[25]  K. Merikangas,et al.  Familial transmission of substance use disorders. , 1998, Archives of general psychiatry.

[26]  R. Pickens,et al.  Extension of a typology of alcohol dependence based on relative genetic and environmental loading. , 1998, Alcoholism, clinical and experimental research.

[27]  R. Wise.  Drug-activation of brain reward pathways. , 1998, Drug and alcohol dependence.

[28]  N. Volkow,et al.  Addiction and imaging of the living human brain. , 1998, Drug and alcohol dependence.

[29]  J. Long,et al.  Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. , 1998, American journal of medical genetics.

[30]  Peter J. Cohen,et al.  Immunization for prevention and treatment of cocaine abuse: legal and ethical implications. , 1997, Drug and alcohol dependence.

[31]  L. Bierut,et al.  Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men , 1997, Psychological Medicine.

[32]  Darrell R. Schroeder,et al.  A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .

[33]  J. Nurnberger,et al.  The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. , 1997, Addiction.

[34]  Wayne Hall,et al.  The Role of Legal Coercion in the Treatment of Offenders with Alcohol and Heroin Problems* , 1997 .

[35]  M A Schuckit,et al.  Comparison of induced and independent major depressive disorders in 2,945 alcoholics. , 1997, The American journal of psychiatry.

[36]  N. Volkow,et al.  Imaging the living human brain: magnetic resonance imaging and positron emission tomography. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  L. Cardon,et al.  Heavy consumption of cigarettes, alcohol and coffee in male twins. , 1997, Journal of studies on alcohol.

[38]  T. Robbins,et al.  Neurobehavioural mechanisms of reward and motivation , 1996, Current Opinion in Neurobiology.

[39]  N. S. Miller,et al.  Prevalence of depression and alcohol and other drug dependence in addictions treatment populations. , 1996, Journal of psychoactive drugs.

[40]  J. Kocsis,et al.  A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. , 1996, JAMA.

[41]  G. Mittleman,et al.  Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence , 1995, Psychopharmacology.

[42]  R. Rothman,et al.  A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development , 1995, Molecular Neurobiology.

[43]  N. Breslau.  Psychiatric comorbidity of smoking and nicotine dependence , 1995, Behavior genetics.

[44]  K. Rice,et al.  GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. , 1994, The Journal of pharmacology and experimental therapeutics.

[45]  D. Carmelli,et al.  Correlations of alcohol consumption with related covariates and heritability estimates in older adult males over a 14- to 18-year period: the NHLBI Twin Study. , 1994, Alcoholism, clinical and experimental research.

[46]  D. Carmelli,et al.  Genetic influence on smoking--a study of male twins. , 1992, The New England journal of medicine.

[47]  R. Bland.  Psychiatric Disorders in America: The Epidemiologic Catchment Area Study , 1992 .

[48]  M. Linnoila,et al.  Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables. , 1991, Archives of general psychiatry.

[49]  T. Beauchamp,et al.  Principles of biomedical ethics , 1991 .

[50]  D S Rae,et al.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.

[51]  J. Helzer,et al.  Smoking, smoking cessation, and major depression. , 1990, JAMA.

[52]  J. Fleiss,et al.  Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. , 1988, JAMA.

[53]  B. Rounsaville,et al.  Psychopathology as a predictor of treatment outcome in alcoholics. , 1987, Archives of general psychiatry.

[54]  M. Schuckit.  The clinical implications of primary diagnostic groups among alcoholics. , 1985, Archives of general psychiatry.

[55]  M M Weissman,et al.  Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. , 1984, Archives of general psychiatry.

[56]  M M Weissman,et al.  Lifetime prevalence of specific psychiatric disorders in three sites. , 1984, Archives of general psychiatry.

[57]  Philipp Nadel.  Informing Americas Policy On Illegal Drugs What We Dont Know Keeps Hurting Us , 2016 .

[58]  O. Gureje,et al.  Alcohol and the developing world : a public health perspective , 2002 .

[59]  J. Mackay,et al.  The Tobacco Atlas , 2002 .

[60]  Ting-kai Li,et al.  Research advances in ethanol metabolism. , 2001, Pathologie-biologie.

[61]  T. B. Üstün,et al.  Cross-cultural views on stigma, valuation, parity, and societal values towards disability , 2001 .

[62]  D. Agarwal.  Genetic polymorphisms of alcohol metabolizing enzymes. , 2001, Pathologie-biologie.

[63]  Ting-kai Li,et al.  Pharmacogenetics of responses to alcohol and genes that influence alcohol drinking. , 2000, Journal of studies on alcohol.

[64]  L. Almasy,et al.  Smoking behavior is under the influence of a major quantitative trait locus on human chromosome 5q , 1999, Genetic epidemiology.

[65]  K. Kendler,et al.  Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. , 1999, The American journal of psychiatry.

[66]  G. Swan.  Implications of genetic epidemiology for the prevention of tobacco use. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[67]  C. Lloyd.  Risk Factors for Problem Drug Use: Identifying vulnerable groups , 1998 .

[68]  A. Jonsen.  The birth of bioethics: the origins and evolution of a demi-discipline. , 1997, Medical humanities review.

[69]  R. Kessler,et al.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. , 1996, The American journal of orthopsychiatry.

[70]  L. Cardon,et al.  The consumption of tobacco, alcohol, and coffee in Caucasian male twins: a multivariate genetic analysis. , 1996, Journal of substance abuse.

[71]  C. Aine.  A conceptual overview and critique of functional neuroimaging techniques in humans: I. MRI/FMRI and PET. , 1995, Critical reviews in neurobiology.

[72]  P. Goldman-Rakic,et al.  Practice guideline for the treatment of patients with substance use disorders: Alcohol, cocaine, opioids , 1995 .

[73]  Key W Ord.  The Collaborative Study on the Genetics of Alcoholism , 1995, Alcohol health and research world.

[74]  R. Kessler,et al.  A twin-family study of alcoholism in women. , 1994, The American journal of psychiatry.

[75]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.

[76]  B. Prusoff,et al.  Psychiatric diagnoses of treatment-seeking cocaine abusers. , 1991, Archives of general psychiatry.

[77]  D. Gerstein,et al.  The Effectiveness of Treatment , 1990 .

[78]  J R Hughes,et al.  Prevalence of smoking among psychiatric outpatients. , 1986, The American journal of psychiatry.

[79]  M. Weissman,et al.  Psychiatric Disorders in Treated Opiate Addicts , 1984 .